A study by Unruh and colleagues demonstrated that the extent and targets of the DNA hypermethylation induced by mutant IDH are highly variable between various IDH mutant cancers (AML, cholangiocarcinomas, melanomas, gliomas), depending on the cellular contexts. This evidence concerns the gene IDH2 and cholangiocarcinoma.